home All News open_in_new Full Article

"Pfizer" un "BioNTech" maksās 740 miljonus dolāru mierizlīgumā par Covid

ASV farmācijas kompānija "Pfizer" un Vācijas biotehnoloģiju uzņēmums "BioNTech" maksās Lielbritānijas GSK un Vācijas "CureVac" 740 miljonus ASV dolāru (635,6 miljoni eiro) un autoratlīdzības, lai panāktu mierizlīgumu juridiskajos strīdos ASV saistībā ar Covid-19 vakcīnu, piektdien paziņoja "CureVac".


today 4 w. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Technology
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics


ID: 381627937
Add Watch Country

arrow_drop_down